Human milk oligosaccharides, or HMOs, are complex carbohydrates found naturally in human milk. HiMO describes a specially produced oligosaccharide with the same molecular structure as a selected HMO, while 2’-FL is the specific HiMO included in Kabrita’s new formula. Baby formula labels can sometimes feel like they require their own dictionary. Alongside familiar words such as protein, vitamins and minerals, parents may now come across terms such as HMO, HiMO, oligosaccharides and 2’-FL. They sound highly scientific, but the main idea is simpler than it seems.
HMO stands for human milk oligosaccharide.
HiMO stands for human-identical milk oligosaccharide.
It describes a specially produced oligosaccharide with the same molecular structure as a selected HMO found naturally in human milk. 2’-FL, short for 2’-fucosyllactose, is one specific type of HMO. It is among the most widely researched human milk oligosaccharides and can be produced in a human-identical form for use in infant formula.
In other words:
HMO is the broader scientific category. HiMO describes a human-identical version used in formula, and 2’-FL is the specific HiMO included in Kabrita’s new formula. By adding HiMO 2’-FL to its updated goat milk formula, Kabrita combines its familiar goat milk foundation with an ingredient developed through advances in early nutrition research. But what exactly is an HMO formula? How does 2’-FL interact with the baby’s gut? Is it a probiotic or prebiotic? And is HMO the same as colostrum? Here is a clear, parent-friendly explanation.
What Are Human Milk Oligosaccharides (HMOs)?
Human milk oligosaccharides, commonly called HMOs, are a diverse group of complex carbohydrates found naturally in human milk. Although they are built from sugar units, HMOs are different from lactose, which is the main carbohydrate in human milk. They are not present simply to make milk taste sweeter.
Researchers have identified more than 100 different HMO structures. Their amounts and combinations may vary naturally between mothers and may also change throughout the breastfeeding journey. Many HMOs are not fully broken down by a baby’s digestive system. Instead, they travel through the digestive tract and reach the intestine, where they can interact with selected gut bacteria and other parts of the developing digestive environment.
HMOs are studied for their role in:
- Interacting with selected gut bacteria
- Supporting activity within the intestinal microbiome
- Participating in the developing gut environment
- Helping researchers understand early nutrition
- Expanding scientific knowledge of human milk composition
Each HMO has its own molecular structure. This means different HMOs may interact with the digestive system and gut bacteria in different ways.
What Is the Difference Between HMO and HiMO?
The two terms are closely connected, but they do not mean exactly the same thing.
HMO refers to a human milk oligosaccharide found naturally in human milk.
HiMO refers to a specially produced oligosaccharide with the same molecular structure as a selected HMO.
The “i” in HiMO stands for identical.
HiMOs are not extracted from human milk. They are produced through controlled processes for use in infant nutrition. This allows selected oligosaccharide structures first identified in human milk to be included in modern infant formulas. For parents comparing an HMO formula, it is helpful to look at which specific HMO or HiMO the product contains rather than focusing only on the general term.
How Do HMOs Interact With Gut Bacteria Like Bifidobacterium?
Different gut bacteria have different abilities.Some species and strains can use particular HMOs, while others cannot. This selectivity is one reason HMOs are studied in relation to the infant microbiome. Certain members of the Bifidobacterium group are especially well known for their ability to use selected HMOs. Bifidobacterium is a group of bacteria commonly studied in the infant gut. Some species and strains possess specialised systems that allow them to break down and use particular oligosaccharides. This does not mean that every HMO feeds every type of Bifidobacterium, or that one ingredient can create a perfect microbiome.The interaction depends on:
- The specific HMO
- The bacterial species and strain
- The baby’s age
- The existing gut microbiome
- Feeding pattern
- Medication exposure
- The broader diet and environment
HMOs should therefore be understood as one part of a complex nutritional and microbial ecosystem. For more information, read our guide to Baby Gut Health and the Infant Microbiome.
What Is 2’-FL?
2’-FL stands for 2’-fucosyllactose. It is one specific type of HMO, made from three sugar units arranged in a particular molecular structure. Parents do not need to remember the chemistry. The important point is that 2’-FL is one of the best-known and most widely researched oligosaccharides found naturally in the milk of many mothers. The amount of 2’-FL in human milk can vary. Some mothers naturally produce higher levels because of genetic factors, while others produce little or no detectable 2’-FL. This natural variation does not mean one mother’s milk is “better” than another’s. Human milk still contains many other valuable nutrients and oligosaccharides regardless of its 2’-FL level.
Why Is 2’-FL Used in Infant Formula?
2’-FL has received significant attention in infant nutrition because:
- Its molecular structure is clearly understood
- It occurs naturally in the milk of many mothers
- It has been widely researched
- It can be produced in a human-identical form
- Selected gut bacteria may be able to use it
- It can be included within a complete infant formula
The 2’-FL used in infant formula has the same molecular structure as the corresponding 2’-FL found naturally in human milk. For this reason, it can be described as a human-identical milk oligosaccharide, or HiMO. Its inclusion should still be considered as one part of the complete formula rather than as a stand-alone solution.
Is the 2’-FL in Kabrita Taken From Human Milk?
No. The 2’-FL used in Kabrita’s infant formula is not taken or extracted from human milk. It is specially produced through a controlled process so that its final molecular structure matches the corresponding 2’-FL found naturally in human milk. This distinction matters because the phrase “human-identical” can sometimes be misunderstood.
What Does “Human-Identical” Mean?
“Human-identical” refers to the molecular structure of the selected oligosaccharide. It does not mean that the ingredient comes directly from human milk. It also does not mean that a formula containing 2’-FL becomes identical to breast milk. Human milk is a living and changing fluid containing many components, including:
- Proteins
- Fats
- Carbohydrates
- Vitamins and minerals
- Enzymes
- Antibodies
- Hormones
- Living cells
- Many different oligosaccharides
A formula containing the HiMO 2’-FL includes one selected human-identical oligosaccharide within its complete nutritional composition. It does not recreate every component or function of human milk.
How Does 2’-FL Interact With the Baby’s Gut?
A baby’s digestive system is home to a community of microorganisms known as the gut microbiome. This community begins developing around birth and continues changing throughout infancy and early childhood.[4]
The infant microbiome may be influenced by:
- Mode of birth
- Gestational age
- Feeding pattern
- Medication use
- Contact with caregivers
- The surrounding environment
- The introduction of complementary foods
2’-FL is not fully digested in the same way as many ordinary carbohydrates. Instead, it can reach the intestine, where selected bacteria may be able to use it. Some members of the Bifidobacterium group are among the bacteria studied for their ability to use specific HMOs, including selected fucosylated oligosaccharides. Different bacterial species and strains have different abilities. Some may use a particular oligosaccharide, while others may not. This selective interaction is one reason 2’-FL is studied in relation to the developing infant gut environment.
Does 2’-FL Create the Perfect Microbiome?
No. There is no single perfect microbiome that applies to every baby. Each baby’s microbial community is influenced by biological, nutritional, medical and environmental factors.
The inclusion of 2’-FL in Kabrita’s new formula represents one nutritional approach to the developing gut environment. It should not be presented as a way to control every aspect of the microbiome. No single ingredient can determine a baby’s overall digestive or immune health.
Is 2’-FL a Probiotic?
No, a probiotic is a selected live microorganism. 2’-FL is not alive. It is an oligosaccharide, which is a type of carbohydrate. The two may both be discussed in relation to the gut microbiome, but they work differently. A simple way to remember the difference is:
-
Probiotics are selected live microorganisms.
-
2’-FL is a human-identical milk oligosaccharide.
Certain bacteria may use 2’-FL, which is why probiotics and oligosaccharides are sometimes discussed together in infant nutrition. Here’s a separate more detailed guide to the BB-12 probiotic.
Is 2’-FL a Prebiotic?
2’-FL can be used by selected bacteria in the gut, which is why it is often discussed alongside prebiotics. However, the terms HiMO and prebiotic should not automatically be used as though they mean exactly the same thing. A prebiotic is generally defined as a substance that is selectively used by microorganisms and provides a demonstrated health benefit.
Whether a specific prebiotic or health claim can be used for 2’-FL may depend on:
- The scientific evidence
- The amount included
- The intended age group
- The complete formula
- Local regulatory requirements
- The exact approved product wording
The simplest accurate explanation for parents is:
2’-FL is a HiMO that can interact with selected bacteria in the developing gut environment.
Is HMO the Same as Colostrum?
No, an HMO is a type of complex carbohydrate found in human milk. Colostrum is the early milk produced during the first days after birth. It is often thicker and more concentrated than mature human milk and contains nutrients and biological components suited to the newborn stage. Colostrum contains HMOs, but it is not itself an HMO.
A simple way to understand the difference is:
- Colostrum is a type of early human milk.
- HMOs are specific carbohydrates found within human milk, including colostrum.
The amount and pattern of HMOs may change as milk transitions from colostrum to mature human milk.
Why Do HiMOs and 2’-FL Make Kabrita’s New Formula Stand Out?
Kabrita is known for its goat milk-based formulas.The inclusion of the HiMO 2’-FL adds another dimension to the new formula by combining Kabrita’s goat milk foundation with an ingredient developed through advances in human milk and early nutrition research.
The new formula brings together:
- A goat milk-based nutritional foundation
- A2 protein naturally associated with its goat milk base
- Goat milk fat
- A specifically selected HiMO
- The widely researched oligosaccharide 2’-FL
- A complete nutritional formula designed for the relevant feeding stage
The key point is not simply that Kabrita contains another ingredient. It is that the formula brings together its goat milk base and a selected HMO-inspired ingredient within one complete nutritional design.
2’-FL Is a Standout Ingredient, Not the Whole Formula
Parents are often encouraged to focus on one headline ingredient. But infant formula should always be considered as a complete nutritional product. Alongside 2’-FL, the complete formula contains other important components, such as:
- A2 protein
- Goat milk fat
- Carbohydrates
- Vitamins
- Minerals
The overall composition matters more than any one ingredient used in isolation. 2’-FL may help distinguish Kabrita’s new formula, but its value comes from how it fits within the complete formulation.
What Should Parents Consider When Choosing Formula?
The inclusion of HiMO 2’-FL may be an important factor for parents comparing formulas, but it should not be the only consideration. Parents should also ask:
- Is the formula suitable for the baby’s age?
- Is 2’-FL clearly listed among the ingredients?
- What other ingredients are included?
- Are the product claims approved locally?
- Does the baby have a diagnosed allergy or medical condition?
- Are the preparation instructions clear?
- Has a healthcare professional recommended a particular formula?
Kabrita’s new formula gives families access to a goat milk-based formula that includes the HiMO 2’-FL within its updated composition. The decision to start or change formula should still reflect the baby’s age, individual needs, medical history and professional healthcare guidance.
What HMO, HiMO and 2’-FL Do Not Mean
Clear and responsible communication is especially important in infant nutrition.
The inclusion of HiMO 2’-FL does not mean that:
- The formula is identical to breast milk
- Every baby will respond in the same way
- The baby will never experience gas or stool changes
- The formula can prevent or treat illness
- 2’-FL creates a perfect microbiome
- Medical advice is no longer needed
- The formula is suitable for every allergy or medical condition
HiMO 2’-FL should be understood as one advanced ingredient within a complete nutritional formula.
It is not a treatment, cure or guarantee of a symptom-free feeding experience.
Common Questions About HMO and 2’-FL
What Does HMO Stand For?
HMO stands for human milk oligosaccharide. It describes a family of complex carbohydrates found naturally in human milk.
What Does HiMO Stand For?
HiMO stands for human-identical milk oligosaccharide. It describes a specially produced oligosaccharide with the same molecular structure as a selected HMO found naturally in human milk.
What Does 2’-FL Stand For?
2’-FL stands for 2’-fucosyllactose. It is one specific type of HMO and the HiMO included in Kabrita’s new formula.
Are HMO, HiMO and 2’-FL the Same Thing?
Not exactly. HMO is the wider scientific family of oligosaccharides found in human milk.HiMO describes a specially produced version with a structure identical to a selected HMO. 2’-FL is one specific HMO and HiMO.
A simple comparison is:
HMO is the category.
HiMO explains the human-identical version.
2’-FL is one specific member of that category.
Is 2’-FL Taken From Human Milk?
No, the 2’-FL used in formula is specially produced to match the molecular structure of the corresponding 2’-FL found naturally in human milk.
Does 2’-FL Make Formula the Same as Breast Milk?
No, adding one human-identical oligosaccharide does not make infant formula identical to breast milk.
Human milk contains many nutrients and biological components that are not recreated by adding 2’-FL.
Is 2’-FL a Probiotic?
No, a probiotic is a live microorganism. 2’-FL is an oligosaccharide, which is a type of carbohydrate.
Does Every Infant Formula Contain 2’-FL?
No, not every infant formula contains 2’-FL. Its inclusion is one of the features that helps distinguish Kabrita’s new formula from formulas that do not contain this HiMO.
Can 2’-FL Prevent Illness?
2’-FL should not be described as preventing or treating illness unless that exact claim has been reviewed and authorised by the relevant regulator. It is more accurate to explain that 2’-FL can interact with selected gut bacteria and forms part of the formula’s nutritional design.
Is HMO the Same as Colostrum?
No, colostrum is the early milk produced after birth. HMOs are complex carbohydrates found within human milk, including colostrum.
Is Kabrita With 2’-FL Suitable for Cow’s Milk Protein Allergy?
Not automatically. Goat milk proteins may be similar enough to cow’s milk proteins to cause reactions in babies with cow’s milk protein allergy.
A goat milk-based formula should not be used for a diagnosed or suspected cow’s milk protein allergy unless recommended by a qualified healthcare professional.
Conclusion: HMO Is the Category, and 2’-FL Is the Standout Ingredient
HMOs are a diverse family of complex carbohydrates found naturally in human milk. HiMOs are specially produced oligosaccharides with molecular structures identical to selected HMOs. 2’-FL is one specific and widely researched HMO—and it is the HiMO included in Kabrita’s new formula. It is not extracted from human milk, it is not a probiotic, and it does not make infant formula identical to breast milk.
Its role is more focused: 2’-FL can interact with selected gut bacteria, including certain members of the Bifidobacterium group, and form part of a modern infant formula designed with the developing gut environment in mind. By including HiMO 2’-FL in its new formula, Kabrita combines its goat milk foundation with an ingredient shaped by advances in human milk and early nutrition research.
For parents, the message is simple:
HMO is the broader scientific category. HiMO describes the human-identical version, and 2’-FL is the specific HiMO that helps make Kabrita’s new formula stand out.
And thankfully, parents do not need to pronounce “2’-fucosyllactose” perfectly during a 3 a.m. feed to understand why it is there.
Sources
Bode L. “Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama.” Glycobiology. 2012;22(9):1147–1162.
https://doi.org/10.1093/glycob/cws074
Thurl S, et al. “Variation of Human Milk Oligosaccharides in Relation to Milk Groups and Lactational Periods.” British Journal of Nutrition. 2010;104(9):1261–1271.
https://doi.org/10.1017/S0007114510002072
Sela DA, et al. “The Genome Sequence of Bifidobacterium longum subsp. infantis Reveals Adaptations for Milk Utilization Within the Infant Microbiome.” Proceedings of the National Academy of Sciences. 2008;105(48):18964–18969.
https://doi.org/10.1073/pnas.0809584105
Stewart CJ, et al. “Temporal Development of the Gut Microbiome in Early Childhood From the TEDDY Study.” Nature. 2018;562:583–588.
https://doi.org/10.1038/s41586-018-0617-x
Gibson GR, et al. “The International Scientific Association for Probiotics and Prebiotics Consensus Statement on the Definition and Scope of Prebiotics.” Nature Reviews Gastroenterology & Hepatology. 2017;14:491–502.
https://doi.org/10.1038/nrgastro.2017.75
Triantis V, Bode L, van Neerven RJJ. “Immunological Effects of Human Milk Oligosaccharides.” Frontiers in Pediatrics. 2018;6:190.
https://doi.org/10.3389/fped.2018.00190
World Health Organization. “Infant and Young Child Feeding.”
https://www.who.int/news-room/fact-sheets/detail/infant-and-young-child-feeding